Gregory Renza
Stock Analyst at Truist Securities
(4.15)
# 487
Out of 5,090 analysts
239
Total ratings
44.66%
Success rate
16.69%
Average return
Main Sectors:
Stocks Rated by Gregory Renza
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals | Assumes: Buy | $812 → $798 | $722.83 | +10.40% | 1 | Nov 24, 2025 | |
| CATX Perspective Therapeutics | Assumes: Buy | $8 → $12 | $2.39 | +402.09% | 7 | Nov 24, 2025 | |
| NRIX Nurix Therapeutics | Assumes: Buy | $23 → $30 | $18.00 | +66.67% | 12 | Nov 24, 2025 | |
| GILD Gilead Sciences | Assumes: Buy | $145 → $140 | $122.42 | +14.36% | 1 | Nov 24, 2025 | |
| AMGN Amgen | Assumes: Hold | $298 → $318 | $340.33 | -6.56% | 18 | Nov 24, 2025 | |
| XNCR Xencor | Initiates: Buy | $29 | $18.05 | +60.66% | 10 | Nov 24, 2025 | |
| VRDN Viridian Therapeutics | Initiates: Buy | $41 | $32.49 | +26.21% | 12 | Nov 24, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $11 | $8.31 | +32.37% | 7 | Nov 24, 2025 | |
| NUVL Nuvalent | Initiates: Buy | $140 | $107.05 | +30.79% | 1 | Nov 24, 2025 | |
| MNKD MannKind | Initiates: Buy | $9 | $5.73 | +57.21% | 2 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $59 | $35.95 | +64.12% | 13 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $8.88 | +57.75% | 4 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $62 | $44.95 | +37.93% | 4 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $10 | $7.19 | +39.08% | 4 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $400 | $331.27 | +20.75% | 3 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $30.68 | +66.23% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $27.43 | +16.66% | 7 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $140 | $109.64 | +27.70% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $35 | $220.51 | -84.13% | 3 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $26 | $26.59 | -2.20% | 16 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $8 | $3.54 | +125.99% | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $5 | $2.04 | +145.70% | 11 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $44.40 | -9.90% | 10 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $182 → $172 | $166.39 | +3.37% | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $113 → $38 | $90.61 | -58.61% | 14 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $12 | $10.62 | +13.05% | 6 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $14 | $10.60 | +32.14% | 10 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $18 | $23.97 | -24.91% | 11 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $68 → $48 | $1.87 | +2,473.73% | 4 | Jan 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $110 → $20 | $8.44 | +136.97% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $16 | $0.83 | +1,821.00% | 1 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $2,160 → $180 | $18.01 | +899.72% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $100 → $80 | $1.06 | +7,447.17% | 5 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $105 → $30 | $0.45 | +6,564.45% | 3 | Jun 2, 2020 |
Regeneron Pharmaceuticals
Nov 24, 2025
Assumes: Buy
Price Target: $812 → $798
Current: $722.83
Upside: +10.40%
Perspective Therapeutics
Nov 24, 2025
Assumes: Buy
Price Target: $8 → $12
Current: $2.39
Upside: +402.09%
Nurix Therapeutics
Nov 24, 2025
Assumes: Buy
Price Target: $23 → $30
Current: $18.00
Upside: +66.67%
Gilead Sciences
Nov 24, 2025
Assumes: Buy
Price Target: $145 → $140
Current: $122.42
Upside: +14.36%
Amgen
Nov 24, 2025
Assumes: Hold
Price Target: $298 → $318
Current: $340.33
Upside: -6.56%
Xencor
Nov 24, 2025
Initiates: Buy
Price Target: $29
Current: $18.05
Upside: +60.66%
Viridian Therapeutics
Nov 24, 2025
Initiates: Buy
Price Target: $41
Current: $32.49
Upside: +26.21%
Nuvation Bio
Nov 24, 2025
Initiates: Buy
Price Target: $11
Current: $8.31
Upside: +32.37%
Nuvalent
Nov 24, 2025
Initiates: Buy
Price Target: $140
Current: $107.05
Upside: +30.79%
MannKind
Nov 24, 2025
Initiates: Buy
Price Target: $9
Current: $5.73
Upside: +57.21%
Nov 24, 2025
Initiates: Buy
Price Target: $59
Current: $35.95
Upside: +64.12%
Nov 24, 2025
Initiates: Buy
Price Target: $14
Current: $8.88
Upside: +57.75%
Nov 24, 2025
Initiates: Buy
Price Target: $62
Current: $44.95
Upside: +37.93%
Nov 24, 2025
Initiates: Hold
Price Target: $10
Current: $7.19
Upside: +39.08%
Nov 24, 2025
Initiates: Buy
Price Target: $400
Current: $331.27
Upside: +20.75%
Nov 24, 2025
Initiates: Buy
Price Target: $51
Current: $30.68
Upside: +66.23%
Nov 24, 2025
Initiates: Buy
Price Target: $32
Current: $27.43
Upside: +16.66%
Nov 24, 2025
Initiates: Buy
Price Target: $140
Current: $109.64
Upside: +27.70%
May 23, 2025
Maintains: Outperform
Price Target: $31 → $35
Current: $220.51
Upside: -84.13%
May 19, 2025
Reiterates: Outperform
Price Target: $26
Current: $26.59
Upside: -2.20%
May 15, 2025
Reiterates: Outperform
Price Target: $8
Current: $3.54
Upside: +125.99%
May 14, 2025
Reiterates: Sector Perform
Price Target: $5
Current: $2.04
Upside: +145.70%
May 14, 2025
Reiterates: Outperform
Price Target: $40
Current: $44.40
Upside: -9.90%
May 7, 2025
Maintains: Outperform
Price Target: $182 → $172
Current: $166.39
Upside: +3.37%
Apr 16, 2025
Maintains: Sector Perform
Price Target: $113 → $38
Current: $90.61
Upside: -58.61%
Mar 26, 2025
Reiterates: Outperform
Price Target: $12
Current: $10.62
Upside: +13.05%
Mar 21, 2025
Maintains: Outperform
Price Target: $16 → $14
Current: $10.60
Upside: +32.14%
Jan 14, 2025
Reiterates: Sector Perform
Price Target: $18
Current: $23.97
Upside: -24.91%
Jan 9, 2025
Maintains: Outperform
Price Target: $68 → $48
Current: $1.87
Upside: +2,473.73%
Nov 5, 2024
Downgrades: Sector Perform
Price Target: $110 → $20
Current: $8.44
Upside: +136.97%
Aug 14, 2024
Reiterates: Outperform
Price Target: $16
Current: $0.83
Upside: +1,821.00%
Jun 27, 2023
Downgrades: Sector Perform
Price Target: $2,160 → $180
Current: $18.01
Upside: +899.72%
Mar 16, 2022
Maintains: Sector Perform
Price Target: $100 → $80
Current: $1.06
Upside: +7,447.17%
Jun 2, 2020
Downgrades: Sector Perform
Price Target: $105 → $30
Current: $0.45
Upside: +6,564.45%